UPC Company Profile and Key Details

Q: Who are the executives of UPC?

Ms. Lin YangChief Financial Officer & DirectorMr. Baochang LiuChief Operating OfficerMr. Gang LaiChief Executive Officer & Chairman

NASDAQ : UPC

Universe Pharmaceuticals

$4.04

-0.29-6.70%

Open: 10:20 AM

58.52

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Universe Pharmaceuticals Inc. (UPC) stock declined over -6.70%, trading at $4.04 on NASDAQ, down from the previous close of $4.33. The stock opened at $4.07, fluctuating between $3.90 and $4.35 in the recent session.

Stock Snapshot

4.33

Prev. Close

2.55M

Market Cap

3.9001

Day Low

-0.5

P/E Ratio

-8.06

EPS (TTM)

0.31

Cash Flow per Share

4.07

Open

631.76K

Number of Shares

4.35

Day High

100%

Free Float in %

10.91

Book Value

29.88K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 03, 2026	4.44	4.90	4.27	4.33	0
Sep 02, 2026	5.10	5.33	3.97	4.77	4.08M
Sep 01, 2026	4.61	4.75	4.26	4.27	9K
Aug 31, 2026	4.78	5.01	4.58	4.58	13.34K
Aug 28, 2026	4.95	5.55	4.58	4.90	18.01K
Aug 27, 2026	5.21	5.50	4.60	5.04	51.74K
Aug 26, 2026	5.03	5.91	5.03	5.32	96.75K
Aug 25, 2026	5.16	5.36	5.03	5.03	12.76K
Aug 24, 2026	5.29	5.36	5.11	5.36	19.46K
Aug 21, 2026	5.18	5.36	5.11	5.30	5.25K
Aug 20, 2026	5.26	5.45	5.03	5.33	17.39K
Aug 19, 2026	5.12	5.60	5.12	5.34	9.59K
Aug 18, 2026	5.56	5.61	5.21	5.23	29.07K
Aug 17, 2026	5.60	5.84	5.53	5.78	23.92K
Aug 14, 2026	5.92	6.10	5.57	5.65	32.36K
Aug 13, 2026	6.01	6.21	5.67	5.87	19.21K
Aug 12, 2026	6.08	6.08	5.57	6.06	24.98K
Aug 11, 2026	7.00	7.00	5.69	5.94	67.45K
Aug 10, 2026	5.50	7.50	5.50	7.09	291.97K
Aug 07, 2026	6.38	6.38	5.51	5.56	69.72K

Contact Details

Ji'An, JX 343100

China

https://www.universe-pharmacy.com 865 718 7555823

About Company

Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.

Stock Peers

ITCI

Intra-Cellular Therapies, Inc.$131.87 LNTH

0.17+0.17%

Lantheus Holdings, Inc.$100.98 ANIP

-1.07-1.46%

ANI Pharmaceuticals, Inc.$71.99 ETON

-2.06-3.32%

Eton Pharmaceuticals, Inc.$59.90 ALKS

-0.84-1.76%

Alkermes plc$46.88 SUPN

-0.06-0.14%

Supernus Pharmaceuticals, Inc.$43.97 PAHC

-1.34-3.36%

Phibro Animal Health Corporation$38.58 HROW

-0.79-2.02%

Harrow Health, Inc.$38.26 INDV

-0.22-0.63%

Indivior Pharmaceuticals Inc$34.83 PETQ

-0.01-0.03%

PetIQ, Inc.$30.98

Company Overview

Universe Pharmaceuticals Inc. (NASDAQ:UPC) closed at $4.04 USD, losing -$0.29 (-6.70%) from the previous close of $4.33. The stock is currently mid-range between its 52-week high and low $2.00 and $17.96. With a market capitalization of about $2.55 million, Universe Pharmaceuticals Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.53). Key stats such as the average daily volume over the past year has been around 2.18 million shares, volume is running light vs its 52-week average. Headquartered in Ji'An, JX, Universe Pharmaceuticals Inc. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Gang Lai, the company employs approximately 216 people and listed since March 23, 2021. Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market.

Technical Performance

UPC has shown mixed momentum, gaining 3.37% over the past week and -17.78% over the past quarter, though year-to-date performance is up 12.86%. Short-term trend indicators are bullishly aligned (SMA20 -19.44%, SMA50 -27.37%, SMA200 -31.79%). The stock’s 14-day RSI is 34.23 (weak momentum), while the ATR of 0.27 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -74.36% below its high and over 12.35% above its low. Average 10-day trading volume of 535.74 thousand shares is below the 3-month average of 2.02 million, indicating normal recent market interest.

Valuation Metrics

Universe Pharmaceuticals Inc. trades at a P/E ratio of -1.25, slightly below the S&P 500 average, with a price-to-sales ratio of 0.15 and a price-to-book ratio of 0.04 suggesting the stock is closer to book value. The P/FCF stands at -0.22, also above market averages.

Dividend & Fair Value

Universe Pharmaceuticals Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$3.62. This means the shares are trading below this model’s fair value.

Shareholding & Insider Activity

Universe Pharmaceuticals Inc. has 631.76 thousand shares outstanding. The public float is 487.25 thousand shares, elevated short interest at 1.02% of float. This equals 6.38 thousand shares. The short ratio is 0.01 days. Institutional investors hold 1.33% of the float. Insiders own 1.44%.

Financial & Profitability Overview

Over the trailing twelve months, Universe Pharmaceuticals generated $32.31M in revenue, or $8.91 per share. Gross margin was 31.93%, operating margin -10.92%, and net profit margin -19.08%. Returns are negative, with ROA at -11.57% and ROE at -15.59%.
On valuation metrics, Universe Pharmaceuticals trades at a P/E of -1.25, P/S of 0.15 and P/B of 0.04. The current ratio is 4.05 and quick ratio is 3.75. Operationally, the company’s inventory turnover is 2.86 and cash conversion cycle is 428.22 days. Debt-to-equity is 0.17, supported by a cash flow-to-debt ratio of -1.25.

Quarterly Financial Highlights

For the quarter ended Sep 30, 2023, Universe Pharmaceuticals posted revenue of $32.31M, down slightly from $40.14M in the prior quarter. Gross profit was $10.32M (margin 31.93%). Operating income was - $3.53M (margin -10.9%). Net income was- $6.16M (EPS - $1.70).
The company ended the quarter with $18.50M in cash and short-term investments, a total debt of $5.48M, and net debt of $197.21K. Total assets were $53.29M, with equity of $39.53M. Financials further reflected stability, with operating cash flow of $1.12M, free cash flow of $1.08M, and capital expenditures of - $44.17K.

Price Forecast & Outlook

Our AI price prediction model suggests that Universe Pharmaceuticals Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 13.39%, with price expected at $4.91 by September 17, 2026, within a range of $3.55 to $6.10 3-Month Outlook: Projected rise of 167.21%, reaching $11.57 by December 02, 2026, with a range of $10.96 to $12.23. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by September 03, 2027, within a range of $0.00 to $37.87.

Key Takeaways

Universe Pharmaceuticals Inc. (NASDAQ:UPC) shares are up 12.86% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Universe Pharmaceuticals Inc. trading at a premium to the broader market with a P/E of -1.25. Our AI forecast model points to short-term strength (13.39% over two weeks), a medium-term rise (167.21% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Universe Pharmaceuticals Inc. (UPC) stock price?

Universe Pharmaceuticals Inc. (NASDAQ: UPC) stock price is $4.04 in the last trading session. During the trading session, UPC stock reached the peak price of $4.35 while $3.90 was the lowest point it dropped to. The percentage change in UPC stock occurred in the recent session was -6.7% while the dollar amount for the price change in UPC stock was - $0.29.

UPC's industry and sector of operation?

The NASDAQ listed UPC is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Universe Pharmaceuticals Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of UPC?

Ms. Lin Yang
Chief Financial Officer & Director
Mr. Baochang Liu
Chief Operating Officer
Mr. Gang Lai
Chief Executive Officer & Chairman

How UPC did perform over past 52-week?

UPC's closing price is 116.5% higher than its 52-week low of $2.00 where as its distance from 52-week high of $17.96 is -75.89%.

How many employees does UPC have?

Number of UPC employees currently stands at 216.

Link for UPC official website?

Official Website of UPC is: https://www.universe-pharmacy.com

How do I contact UPC?

UPC could be contacted at phone 865 718 7555823 and can also be accessed through its website. UPC operates from No. 265, Jingjiu Avenue, Ji'An, JX 343100, China.

How many shares of UPC are traded daily?

UPC stock volume for the day was 29.88K shares. The average number of UPC shares traded daily for last 3 months was 2.18M.

What is the market cap of UPC currently?

The market value of UPC currently stands at $2.55M with its latest stock price at $4.04 and 631.76K of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	216
Beta	1.53
Sales or Revenue	$32.31M
5Y Sales Change%	5.564%
Fiscal Year Ends	September
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

UPC Company Profile and Key Details

Universe Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Stock Snapshot

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways